- Report
- July 2024
- 100 Pages
Global
From €3259EUR$3,750USD£2,841GBP
- Report
- June 2024
- 200 Pages
Global
From €6908EUR$7,950USD£6,022GBP
- Report
- June 2024
- 200 Pages
Global
From €6908EUR$7,950USD£6,022GBP
- Report
- June 2024
- 200 Pages
Global
From €6908EUR$7,950USD£6,022GBP
- Report
- June 2024
- 200 Pages
Global
From €6908EUR$7,950USD£6,022GBP
- Report
- February 2024
- 30 Pages
United States
€1955EUR$2,250USD£1,704GBP
- Report
- January 2022
- 90 Pages
Global
From €1738EUR$2,000USD£1,515GBP
- Report
- January 2022
- 90 Pages
Global
From €1738EUR$2,000USD£1,515GBP
- Report
- February 2021
- 35 Pages
Global
From €2824EUR$3,250USD£2,462GBP
- Report
- December 2020
- 60 Pages
Global
From €2824EUR$3,250USD£2,462GBP
- Report
- September 2025
- 70 Pages
India
From €3041EUR$3,500USD£2,651GBP
- Report
- September 2025
- 70 Pages
India
From €3041EUR$3,500USD£2,651GBP
- Report
- September 2025
- 70 Pages
India
From €3041EUR$3,500USD£2,651GBP
- Report
- August 2025
- 86 Pages
India
From €3041EUR$3,500USD£2,651GBP
- Report
- December 2024
- 70 Pages
India
From €3041EUR$3,500USD£2,651GBP
- Report
- August 2024
- 82 Pages
Japan
From €3041EUR$3,500USD£2,651GBP
- Report
- August 2024
- 82 Pages
Japan
From €3041EUR$3,500USD£2,651GBP
- Report
- April 2024
- 180 Pages
Global
From €3910EUR$4,500USD£3,409GBP
- Report
- February 2024
- 182 Pages
Global
From €3910EUR$4,500USD£3,409GBP
- Report
- February 2024
- 176 Pages
Global
From €3910EUR$4,500USD£3,409GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more